UPDATE : Thursday, December 12, 2019
상단여백
2 orphan drugs find manufacturers in Korea
Two orphan drugs, Dapsone and Mexiletine, which have been in supply shortag...
by Lee Hye-seon  |  2017-10-12 15:48
라인
Roche Korea’s lung cancer drug increases cost-effectiveness
Roche Korea said Thursday Alecensa (ingredient: alectinib) would get cheape...
by Marian Chu  |  2017-10-12 14:59
라인
Rethink obesity, says Novo Nordisk Korea
Obesity should no longer be seen as the result of individuals’ habits but r...
by Marian Chu  |  2017-10-12 11:20
라인
AstraZeneca’s ovarian cancer drug more affordable
AstraZeneca Korea said Friday its ovarian cancer drug Lynparza began to rec...
by Marian Chu  |  2017-10-11 18:14
라인
Boryung to sell antihypertensive drugs in SE Asia
South Korea’s Boryung Pharmaceutical said it would sell its antihypertensiv...
by Lee Hye-seon  |  2017-10-11 16:02
라인
Daewoong to sell Novartis’ osteoporosis drug
Daewoong pharmaceutical said Wednesday it acquired marketing and commercial...
by Marian Chu  |  2017-10-11 11:39
라인
Green Cross units sign MOU with Sudan Central Lab
Green Cross MS and Green Cross Laboratories have signed a memorandum of und...
by Lee Han-soo  |  2017-10-10 15:53
라인
SK Chemicals ‘Skyzoster’ wins sales approval
SK Chemicals received the sales approval for Skyzoster, a shingles vaccine,...
by Lee Han-soo  |  2017-10-10 12:16
라인
Immunotherapy developers engage in fierce competition to expand indications
Bristol-Myers Squibb and Merck & Co are conducting several clinical trials ...
by Marian Chu  |  2017-10-05 06:00
라인
Dongkook Pharm, Madagascar government to develop natural medicines
Dongkook Pharmaceuticals said Friday that it has signed an agreement with t...
by Lee Han-soo  |  2017-09-29 17:39
라인
AbbVie’s hepatitis C treatment approved in Japan
AbbVie said Thursday that its G/P (glecaprevir/pibrentasivr) treatment, sho...
by Marian Chu  |  2017-09-29 12:03
라인
Korea lags behind osteoporosis prevention and treatment
Osteoporosis prevention and treatment has been rather overlooked in Korea, ...
by Marian Chu  |  2017-09-29 10:21
라인
World’s best-selling drug Humira gains insurance coverage in Korea
AbbVie Korea said Thursday its blockbuster biologic Humira gained nationwid...
by Marian Chu  |  2017-09-28 19:02
라인
Amgen Korea’s osteoporosis treatment gets insurance coverage
Amgen Korea said Thursday its “first and only” biologic treatment for osteo...
by Marian Chu  |  2017-09-28 19:02
라인
Korean drugmakers’ smart factories at ‘base level’
An increasing number of Korean pharmaceutical firms have built smart factor...
by Nam Doo-hyun  |  2017-09-28 16:00
라인
Drugmakers need to differentiate big data from ‘large data’
It is necessary for Korean pharmaceutical companies to distinguish big data...
by Nam Doo-hyun  |  2017-09-27 17:44
라인
Exelixis’ kidney cancer drug gains approval in Korea
The Ministry of Food and Drug Safety approved Friday Exelixis’ kidney drug ...
by Marian Chu  |  2017-09-27 17:44
라인
Korean combos, incrementally modified drugs to get insurance benefits
Korean combination drugs for hypertension, diabetes, and hyperlipidemia, an...
by Lee Hye-seon  |  2017-09-27 11:29
라인
Ilyang presents leukemia treatment’s clinical results
Ilyang Pharmaceuticals Tuesday released its phase 3 clinical trial result o...
by Lee Han-soo  |  2017-09-26 17:31
라인
Ministry changes dosage recommendation for Bayer’s blood-thinning drug
The Ministry of Food and Drug Safety said Friday it has revised dosage reco...
by Marian Chu  |  2017-09-26 16:24
여백
여백
여백
Back to Top